Please login to the form below

Not currently logged in

Lilly’s Q3 earnings slump on COVID-19 development costs, pricing pressures

Earnings were particularly impacted by lower demand for top diabetes drug Trulicity

Keytruda growth helps Merck to offset COVID-19 impact in Q3

Merck & Co HQProfits beat expectations in the third quarter of 2020

Novartis weathers the COVID-19 storm in Q3, lifts outlook

Novartis buildingCore operating income increased by 11%, profits from net income drop

Bayer pays an initial $2bn for gene therapy firm AskBio

Bayer symbolAcquisition will expand Bayers’s pipeline with preclinical/clinical candidates

Lilly buys biotech firm Disarm Therapeutics for $135m

Eli Lilly new HQDeal could eventually be worth up to $1.36bn

Roche to collaborate with Dyno on gene therapies for CNS/liver diseases

Dyno will use its CapsidMap platform to develop novel AAV vectors for improved gene therapies

J&J signs deal with EU for 200 million COVID-19 vaccine doses

J&J cottonwood driveEU member states will have an option to secure 200 million additional doses

BMS picks up cardiovascular specialist MyoKardia for $13.1bn

BMS buildingAcquisition will bolster pipeline with targeted cardiovascular therapies

Business in the USAHealth coverage across state lines

Despite a total lack of legislative wins, the new administration has made its presence felt at home and abroad

  • Ho_Ung_KimStanding out in a crowd

    Celltrion Healthcare’s Ho-Ung Kim on pricing, market access and regulatory challenges for successfully developing biosimilars

  • HeadsThe diseased organisation

    Like humans, organisations can be afflicted by genetic disorders that hinder performance and threaten survival but these can be understood and cured

COVID-19 Updates and Daily News

Featured jobs


Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

How will COVID-19 affect uptake of vaccinations against other diseases?...
Top 10 Reasons Why Virtual Collaboration and Medical Education Will Persist in the New Normal
Even after the pandemic is long behind us, virtual collaboration will become mainstay in Pharma....
Living With Chronic Illness (Series one)...